• 10.18.17

    Jerry W. Blackwell Wins Minnesota Diversity & Inclusion Award

    The first annual Minnesota Lawyer-Diversity & Inclusion Awards honor those who have contributed to the advancement of diversity and inclusion in the practice of law, going above and beyond in creating a more diverse and inclusive community. When Jerry Blackwell founded Blackwell Burke P.A., he wove excellence and diversity into the firm’s DNA based on his longstanding commitment to both: “I wanted to build a law firm doing institutional work where diversity lives as a leadership priority and to be an example of how a diverse environment can work in fact and not just as a marketing slogan or aspirational…
  • 09.27.17

    Three Blackwell Burke P.A. Attorneys Listed on the Benchmark Litigation 2017 “Under 40 Hotlist”

    The Benchmark Litigation “2017 40 under 40 List” honors the achievements of the nation’s most accomplished legal partners of the age of forty or younger.  Blackwell Burke P.A. is proud of its three attorneys receiving this recognition. Gerardo “Jerry” Alcazar’s practice includes products liability, commercial litigation, and other complex matters often involving high stakes litigation. He serves as national trial and litigation counsel for a U.S. Fortune 100 global innovation conglomerate, defending against allegations of negligent design and manufacture in safety and chemical products nationwide. Jamal Faleel’s national practice includes representing Fortune 500 companies in complex, high-stakes litigation, with a…
  • 05.31.17

    Blackwell Burke P.A. Secures Dismissal of Putative, National Window Class Action

    Blackwell Burke P.A. recently secured a complete defense victory on behalf of a national window manufacturer. Plaintiffs alleged negligent product design and manufacture, breach of express and implied warranties, and fraud, on behalf of a putative, national consumer class in a Minnesota federal district court. The lawsuit arose from plaintiffs’ contention that the insulated glass units in their windows had failed, and that the remedies provided by the manufacturer under the terms of the applicable warranties were inadequate. Plaintiffs sought to void the warranties, arguing, inter alia, that they were unconscionable and failed of their essential purpose. Blackwell Burke P.A.,…
  • 03.01.17

    Benchmark Litigation Presents Blackwell Burke P.A. with Minnesota Firm of the Year Award

    On February 16, 2017, Blackwell Burke was honored as the “Minnesota Firm of the Year” at the Benchmark Litigation 2017 US awards. The event, held at the Essex House Hotel in New York City, recognized the top litigation firms in all 50 states. Partner Peter Goss attended the Benchmark Litigation 2017 US Awards ceremony and accepted the award on the Firm’s behalf. Now in its tenth year, Benchmark Litigation is “the definitive guide to America’s leading litigation firms and attorneys.” Firms are selected for inclusion in the guide based on interviews with the nation’s leading private practice lawyers and in-house…
  • 09.08.16

    Peter Goss Analyzes New Jersey Summary Judgment Order in Talc Suits against Johnson & Johnson

    Peter Goss was quoted in Law360’s analysis of a recent New Jersey trial court ruling in the Johnson & Johnson talc litigation. The order excluded the plaintiffs’ experts’ testimony and dismissed the claims of two women who alleged that exposure to bath talc caused their ovarian cancer. (“J&J Talc Suits Show Evidence Standards Vary Among Courts,” available with subscription here.) The decision contrasts with the eight-figure verdicts against Johnson & Johnson in recent trials of talc cases in St. Louis. Goss explained that the different outcomes are partly due to different standards for evaluating expert testimony: "Even though New Jersey…
  • 08.29.16

    Peter Goss Comments on Emerging Appellate Split on Generic Drug Preemption

    Peter Goss commented for Law360 on a recent ruling by the New Jersey Supreme Court finding no federal preemption where the generic drug manufacturer’s label for metoclopramide (Reglan) did not match that of the brand.  (“NJ Reglan Ruling Widens Generic Label Preemption Split,” available with subscription here.)  Goss noted that the decision conflicted with Fifth and Sixth Circuit rulings that failure-to-warn claims against generic Reglan manufacturers were preempted, even though the generic and brand labels did not match.  “This could mean that at some point, the U.S. Supreme Court is going to need to resolve the split,” Goss noted.   Mr. Goss focuses his…

Interested in learning more?

Email Disclaimer Close

Sending us an email will not make you a client of our firm. Until we have agreed to represent you, nothing you send us will be confidential or privileged.

If your email is related to representation, the best way for you to inquire about a possible representation is to call a Blackwell Burke P.A. attorney at one of the telephone numbers listed on our Attorney's page. An attorney will first take you through our conflict of interest procedure and see that you are put in touch with the lawyer best suited to handle your matter.

If you proceed with an email, you confirm that you have read and understand this notice. To proceed, click I Agree.